Arcturus Therapeutics

Arcturus Therapeutics News & Events

SEC Filing Details

Document Details

Form
Filing Date
Jan 2, 2019
Document Date
Jan 1, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Arcturus Therapeutics, Inc.
Issuer
Arcturus Therapeutics Ltd.
Filer
SASSINE ANDY